Key result
HTLV-II coinfection did not adversely affect HIV-1 disease progression in a patient who maintained high CD4+ counts and low viral loads without antiretroviral therapy for over six years.
This case suggests that coinfection with HTLV-II does not adversely affect the course of HIV disease, potentially contributing to long-term non-progression.
Answers are grounded in this paper and cite their sources.
Should not alter HIV monitoring for HTLV-II coinfection; single case leaves open any broader role in non-progression.
A 37-year-old man coinfected with HIV-1 and human T-lymphotropic virus type II presumably through injection drug use had a high CD4+ count and low HIV viral load without anti-retroviral therapy for over six years. As an HIV long-term non-progressor, his case supports the hypothesis that coinfection with HTLV-II does not adversely affect the course of HIV disease.
No takes yet. Share an insight, caveat, or question.
Willy et al. (1999) studied this question. HTLV-II coinfection did not adversely affect HIV-1 disease progression in a patient who maintained high CD4+ counts and low viral loads without antiretroviral therapy for over six years.
Synapse has enriched 10 related papers. Consider them for comparative context: